| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $12.1B | $12.3B | $11.5B | $11.2B | $3.3B | $2.6B | — |
| Cost of Revenue | $8.6B | $8.7B | $9.0B | $8.7B | $8.0B | $8.0B | $6.9B | — |
| Gross Profit | $3.0B | — | — | — | — | $0.9B | $0.7B | $0.6B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| SG&A Expense | $1.5B | $2.5B | $2.2B | $1.5B | $1.4B | $1.6B | $1.5B | $1.3B |
| Operating Income | $1.4B | $1.2B | $1.5B | $1.6B | $2.1B | $1.8B | $1.6B | $1.4B |
| Net Income | $1.2B | $0.3B | $0.7B | $0.9B | $1.3B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $2.41 | $0.73 | $1.43 | $1.85 | $2.67 | $0.41 | $0.26 | $0.18 |
| EPS (Diluted) | $2.40 | $0.72 | $1.42 | $1.84 | $2.66 | $0.41 | $0.26 | $0.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.9B | $20.9B | $22.1B | $22.4B | $22.2B | $22.3B | $22.2B | $10.4B |
| Current Assets | $3.1B | $3.1B | $3.4B | $3.0B | $2.7B | $2.9B | $2.7B | $1.9B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.6B | $0.2B | $0.1B |
| Total Liabilities | $12.0B | $12.4B | $13.2B | $13.6B | $13.6B | $14.4B | $14.8B | $6.6B |
| Current Liabilities | $4.3B | $3.2B | $4.4B | $3.5B | $3.3B | $3.3B | $2.1B | $2.3B |
| Stockholders' Equity | $8.9B | $8.4B | $8.7B | $8.8B | $8.6B | $7.9B | $7.4B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $2.0B | $1.0B | $1.2B | $1.5B | $1.8B | $1.1B | $1.0B |
| Investing Cash Flow | $-0.5B | $-0.4B | $-0.4B | $-0.4B | $-0.3B | $-0.2B | $-5.2B | $-0.6B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.5B | $0.5B | $0.4B | $0.4B | $0.3B |
| Financing Cash Flow | $-1.2B | $-1.7B | $-0.6B | $-0.7B | $-1.6B | $-1.4B | $4.1B | $-0.5B |